Back to results
WithdrawnPhase 3

Anti-suicidal Effects of Buprenorphine In Depressed Individuals

NCT05427981

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

New York State Psychiatric Institute

New York, New York, United States

View on ClinicalTrials.gov
Anti-suicidal Effects of Buprenorphine In Depressed Individuals — TrialFind